SC
TMO icon

Stephens Consulting’s Thermo Fisher Scientific TMO Stock Holding History

Stephens Consulting’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.37K Buy
+11
New +$6.22K ﹤0.01% 272
2025
Q3 		– Sell
-25
Closed -$10.1K – 1088
2025
Q2 		$10.1K Buy
25
+10
+67% +$4.18K ﹤0.01% 324
2025
Q1 		$7.46K Sell
15
-34
-69% -$18.4K ﹤0.01% 358
2024
Q4 		$25.5K Hold
49
– – 0.01% 248
2024
Q3 		$30.3K Sell
49
-5
-9% -$2.96K 0.01% 228
2024
Q2 		$29.9K Buy
54
+29
+116% +$16.6K 0.01% 230
2024
Q1 		$14.5K Sell
25
-24
-49% -$13.5K ﹤0.01% 282
2023
Q4 		$26K Hold
49
– – 0.01% 229
2023
Q3 		$24.8K Hold
49
– – 0.01% 229
2023
Q2 		$25.6K Hold
49
– – 0.01% 226
2023
Q1 		$28.2K Hold
49
– – 0.02% 220
2022
Q4 		$27K Hold
49
– – 0.02% 214
2022
Q3 		$24.9K Hold
49
– – 0.02% 236
2022
Q2 		$26.6K Hold
49
– – 0.02% 225
2022
Q1 		$28.9K Buy
49
+25
+104% +$14.4K 0.02% 235
2021
Q4 		$16K Buy
+24
New +$15K 0.01% 336

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stephens Consulting's TMO Position: Q4 2025 in Review

Stephens Consulting opened a new position in Thermo Fisher Scientific (TMO) in Q4 2025: 11 shares worth $6.37K. The stake represents ﹤0.01% of the portfolio and ranks #272 among its holdings. This is a return to the name: Stephens Consulting previously reported a position in TMO as recently as Q2 2025.

Stephens Consulting first reported a position in TMO in Q4 2021 and has held it in 16 quarters since. The position peaked at $30.3K in Q3 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Stephens Consulting held 11 shares of Thermo Fisher Scientific worth $6.37K as of Q4 2025.
  • Thermo Fisher Scientific was a new Stephens Consulting position in Q4 2025.
  • Thermo Fisher Scientific made up ﹤0.01% of Stephens Consulting's portfolio in Q4 2025, its #272 holding.
  • Stephens Consulting first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 16 quarters since.
  • Stephens Consulting's Thermo Fisher Scientific position peaked at $30.3K in Q3 2024.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.